JASPER THERAPEUTICS, INC. (JSPR) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $322.01M; Retained Earnings (Accumulated Deficit)USD $-320.60M; Stockholders' Equity Attributable to ParentUSD $1.41M.
- 2026-03-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $321.24M; Retained Earnings (Accumulated Deficit)USD $-317.84M; Stockholders' Equity Attributable to ParentUSD $3.40M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $320.82M; Retained Earnings (Accumulated Deficit)USD $-316.67M; Stockholders' Equity Attributable to ParentUSD $4.15M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $319.14M; Retained Earnings (Accumulated Deficit)USD $-307.57M; Stockholders' Equity Attributable to ParentUSD $11.57M.
JASPER THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00K | $322.01M | $-320.60M | $1.41M | 3 month · $764.00K 6 month · $1.19M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $3.00K | $321.24M | $-317.84M | $3.40M | 3 month · $423.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.00K | $320.82M | $-316.67M | $4.15M | 12 month · $6.71M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.00K | $319.14M | $-307.57M | $11.57M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $2.00K | $312.33M | $-288.83M | $23.50M | 3 month · $1.82M 6 month · $3.63M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $2.00K | $304.35M | $-262.11M | $42.24M | 3 month · $1.81M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.00K | $302.54M | $-240.87M | $61.67M | 12 month · $6.62M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.00K | $300.23M | $-216.55M | $83.68M | 3 month · $2.00M 9 month · $4.65M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $2.00K | $298.22M | $-197.91M | $100.31M | 3 month · $1.48M 6 month · $2.65M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.00K | $296.56M | $-183.33M | $113.23M | 3 month · $1.17M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.00K | $248.04M | $-169.60M | $78.44M | 12 month · $5.21M | 12 month · $9.00K | 12 month · $725.00K | (m) | (m) |
| 2023-09-30 | $11.00K | $247.14M | $-153.02M | $94.13M | 3 month · $1.40M 9 month · $4.05M | 3 month · $1.00K 9 month · $8.00K | 9 month · $725.00K | (m) | (m) |
| 2023-06-30 | $11.00K | $245.67M | $-135.47M | $110.20M | 3 month · $1.39M 6 month · $2.66M | 3 month · $1.00K 6 month · $7.00K | 6 month · $725.00K | (m) | (m) |
| 2023-03-31 | $11.00K | $244.58M | $-119.39M | $125.20M | 3 month · $1.27M | 3 month · $6.00K | 3 month · $725.00K | (m) | 3 month · $96.93M |
| 2022-12-31 | $4.00K | $141.12M | $-105.14M | $35.99M | 12 month · $4.09M | 12 month · $10.00K | (m) | (m) | (m) |
| 2022-09-30 | $4.00K | $139.49M | $-91.92M | $47.56M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $4.00K | $138.84M | $-80.06M | $58.78M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $4.00K | $137.76M | $-69.66M | $68.11M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $4.00K | $136.96M | $-67.45M | $69.52M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $4.00K | $136.99M | $-58.39M | $78.60M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $187.00 | $10.15M | $-5.15M | $-52.60M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $150.00 | $6.58M | $-1.58M | $-44.55M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.00K | $1.68M | $-36.81M | $-35.13M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $5.44M | $-442.35K | $-25.64M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $5.24M | $-241.16K | $-15.13M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $4.96M | $40.90K | $-6.17M | (m) | (m) | (m) | $101.79M | (m) |
| 2019-12-31 | (m) | $5.60M | $-596.38K | $-4.73M | (m) | (m) | (m) | $101.69M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $24.00K | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |